|
KMID : 0941820100200010025
|
|
Korean Journal of Clinical Pharmacy
2010 Volume.20 No. 1 p.25 ~ p.29
|
|
|
Pharmacokinetic Interaction Between Atorvastatin and Nifedipine
|
|
Moon Hong-seop
Choi Jun-Shik
|
|
|
Abstract
|
|
|
|
The purpose of this study was to investigate the effect of atorvastatin on the pharmacokinetics of nifedipine (6 mg/kg) after oral administration of nifedipine with or without atorvastatin (0.5 and 2.0 mg/kg) in rats, and also was to evaluate to the effect of atorvastatin on the CYP3A4 activity. The 50% inhibiting concentration (IC50) values of atorvastatin on CYP3A4 activity is 46.1 μM. Atorvastatin inhibited CYP3A4 enzyme activity in a concentration-dependent manner. Coadministration of atorvastatin increased significantly (p<0.05, 2.0 mg/kg) the plasma concentration-time curve (AUC) and the peak concentration (Cmax) of nifedipine compared to the control group. The relative bioavailability (RB%) of nifedipine was increased from 1.15- to 1.37-fold. Coadministration of atorvastatin did not significantly change the terminal half-life (T1/2) and the time to reach the peak concentration (Tmax) of nifedipine. Based on these results, we can make a conclusion that the significant changes of these pharmacokinetic parameters might be due to atorvastatin, which possesses the potency to inhibit the metabolizing enzyme (CYP3A4) in the liver and intestinal mucosa, and also inhibit the P-glycoprotein (P-gp) efflux pump in the intestinal mucosa. It might be suggested that atorvastatin altered disposition of nifedipine by inhibition of both the first-pass metabolism and P-glycoprotein efflux pump in the small intestine of rats. In conclusion, the presence of atorvastatin significantly enhanced the oral bioavailability of nifedipine, suggesting that concurrent use of atorvastatin with nifedipine should require close monitoring for potential drug interation.
|
|
|
KEYWORD
|
|
|
Nifedipine, Atorvastatin, Pharmacokinetics, Bioavailability, CYP3A4, P-gp
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|